Literature DB >> 32455912

Erratum: Boland, P.M., et al. Immunotherapy for Colorectal Cancer, Cancers 2017, 9, 50.

Patrick M Boland1, Wen Wee Ma2.   

Abstract

The authors wish to make the following corrections to this paper [...].

Entities:  

Year:  2020        PMID： 32455912      PMCID： PMC7281758          DOI： 10.3390/cancers12051320

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  1 in total

1.  Erratum: Boland, P.M., et al. Immunotherapy for Colorectal Cancer, Cancers 2017, 9, 50.

Authors:  Patrick M Boland; Wen Wee Ma
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639
  1 in total
  6 in total

1.  Erratum: Boland, P.M., et al. Immunotherapy for Colorectal Cancer, Cancers 2017, 9, 50.

Authors:  Patrick M Boland; Wen Wee Ma
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

2.  Post-transcriptional suppression of G protein-coupled receptor 15 (GPR15) by microRNA-1225 inhibits proliferation, migration, and invasion of human colorectal cancer cells.

Authors:  Yuehui Guo; Qingyun Zhu; Shiwei Chen; Yanxiang Li; Daiquan Fu; Delin Qiao; Caifang Ni
Journal:  3 Biotech       Date:  2021-02-23       Impact factor: 2.406

3.  Minimally Invasive Preclinical Monitoring of the Peritoneal Cavity Tumor Microenvironment.

Authors:  Zachary Spencer Dunn; Yan-Ruide Li; Yanqi Yu; Derek Lee; Alicia Gibbons; James Joon Kim; Tian Yang Zhou; Mulin Li; Mya Nguyen; Xinjian Cen; Yang Zhou; Pin Wang; Lili Yang
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

4.  Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer.

Authors:  Haishan Lin; Bangwei Cao
Journal:  Dis Markers       Date:  2022-07-27       Impact factor: 3.464

Review 5.  Myeloid-Derived Suppressor Cells in Colorectal Cancer.

Authors:  Izabela Sieminska; Jarek Baran
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

Review 6.  Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies.

Authors:  Norman J Galbraith; Colin Wood; Colin W Steele
Journal:  Cancers (Basel)       Date:  2021-07-16       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.